Costa Rica vs Korea: Hypertension effective treatment coverage (controlled hypertension)
Costa Rica
49.7%
in 2019
Korea
52.6%
in 2019
Costa Rica rank
4th
Korea rank
2nd
Hypertension effective treatment coverage (controlled hypertension) over time
- Costa Rica
- Korea
How they compare
Korea currently reports 52.6% against 49.7% in Costa Rica, a difference of 2.9%.
That makes Korea's figure about 1.1 times Costa Rica's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Costa Rica ahead.
Costa Rica ranks 4th and Korea ranks 2nd of 193 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Korea in 2.
Head to head by decade
| Decade | Costa Rica | Korea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11.7% | 7.8% | 3.9% | Costa Rica |
| 2000s | 21.4% | 25.7% | 4.2% | Korea |
| 2010s | 41.1% | 47.0% | 5.8% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Costa Rica or Korea?
- Korea, at 52.6% against 49.7% in Costa Rica as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Costa Rica and Korea?
- 2.9%, with Korea ahead.
- How many years of comparable data are there for Costa Rica and Korea?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Korea rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Costa Rica ranks 4th and Korea ranks 2nd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.